520 related articles for article (PubMed ID: 34390123)
1. Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A.
Gao W; Huang Z; Duan J; Nice EC; Lin J; Huang C
Mol Oncol; 2021 Dec; 15(12):3527-3544. PubMed ID: 34390123
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of cancer cells towards Cisplatin and Carboplatin by protein kinase D inhibitors through modulation of ATP7A/B (copper transport ATPases).
Janardhanan P; Somasundaran AK; Balakrishnan AJ; Pilankatta R
Cancer Treat Res Commun; 2022; 32():100613. PubMed ID: 35908410
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into anticancer mechanisms of elesclomol: More than a prooxidant drug.
Gao J; Wu X; Huang S; Zhao Z; He W; Song M
Redox Biol; 2023 Nov; 67():102891. PubMed ID: 37734229
[TBL] [Abstract][Full Text] [Related]
4. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells.
Nagai M; Vo NH; Shin Ogawa L; Chimmanamada D; Inoue T; Chu J; Beaudette-Zlatanova BC; Lu R; Blackman RK; Barsoum J; Koya K; Wada Y
Free Radic Biol Med; 2012 May; 52(10):2142-50. PubMed ID: 22542443
[TBL] [Abstract][Full Text] [Related]
5. Copper Transporter ATP7A (Copper-Transporting P-Type ATPase/Menkes ATPase) Limits Vascular Inflammation and Aortic Aneurysm Development: Role of MicroRNA-125b.
Sudhahar V; Das A; Horimatsu T; Ash D; Leanhart S; Antipova O; Vogt S; Singla B; Csanyi G; White J; Kaplan JH; Fulton D; Weintraub NL; Kim HW; Ushio-Fukai M; Fukai T
Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2320-2337. PubMed ID: 31554420
[TBL] [Abstract][Full Text] [Related]
6. The cytotoxicity of the anticancer drug elesclomol is due to oxidative stress indirectly mediated through its complex with Cu(II).
Hasinoff BB; Yadav AA; Patel D; Wu X
J Inorg Biochem; 2014 Aug; 137():22-30. PubMed ID: 24798374
[TBL] [Abstract][Full Text] [Related]
7. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy.
Zheng P; Zhou C; Lu L; Liu B; Ding Y
J Exp Clin Cancer Res; 2022 Sep; 41(1):271. PubMed ID: 36089608
[TBL] [Abstract][Full Text] [Related]
8. Copper stabilizes the Menkes copper-transporting ATPase (Atp7a) protein expressed in rat intestinal epithelial cells.
Xie L; Collins JF
Am J Physiol Cell Physiol; 2013 Feb; 304(3):C257-62. PubMed ID: 23174565
[TBL] [Abstract][Full Text] [Related]
9. Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth.
Buccarelli M; D'Alessandris QG; Matarrese P; Mollinari C; Signore M; Cappannini A; Martini M; D'Aliberti P; De Luca G; Pedini F; Boe A; Biffoni M; Pallini R; Ricci-Vitiani L
J Exp Clin Cancer Res; 2021 Jul; 40(1):228. PubMed ID: 34253243
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the apico-basolateral trafficking polarity of the homologous copper-ATPases ATP7A and ATP7B.
Ruturaj ; Mishra M; Saha S; Maji S; Rodriguez-Boulan E; Schreiner R; Gupta A
J Cell Sci; 2024 Mar; 137(5):. PubMed ID: 38032054
[TBL] [Abstract][Full Text] [Related]
11. Akt2 (Protein Kinase B Beta) Stabilizes ATP7A, a Copper Transporter for Extracellular Superoxide Dismutase, in Vascular Smooth Muscle: Novel Mechanism to Limit Endothelial Dysfunction in Type 2 Diabetes Mellitus.
Sudhahar V; Okur MN; Bagi Z; O'Bryan JP; Hay N; Makino A; Patel VS; Phillips SA; Stepp D; Ushio-Fukai M; Fukai T
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):529-541. PubMed ID: 29301787
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II).
Yadav AA; Patel D; Wu X; Hasinoff BB
J Inorg Biochem; 2013 Sep; 126():1-6. PubMed ID: 23707906
[TBL] [Abstract][Full Text] [Related]
13. Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma.
Li Y; Yang J; Zhang Q; Xu S; Sun W; Ge S; Xu X; Jager MJ; Jia R; Zhang J; Fan X
Oncogene; 2022 Jul; 41(27):3539-3553. PubMed ID: 35697803
[TBL] [Abstract][Full Text] [Related]
14. The interplay between copper metabolism and microbes: in perspective of host copper-dependent ATPases ATP7A/B.
Zhou Y; Zhang L
Front Cell Infect Microbiol; 2023; 13():1267931. PubMed ID: 38106478
[TBL] [Abstract][Full Text] [Related]
15. Adipocyte-specific disruption of ATPase copper transporting α in mice accelerates lipoatrophy.
Tao C; Wang Y; Zhao Y; Pan J; Fan Y; Liang X; Cao C; Zhao J; Petris MJ; Li K; Wang Y
Diabetologia; 2019 Dec; 62(12):2340-2353. PubMed ID: 31396659
[TBL] [Abstract][Full Text] [Related]
16. The P-type ATPase transporter ATP7A promotes angiogenesis by limiting autophagic degradation of VEGFR2.
Ash D; Sudhahar V; Youn SW; Okur MN; Das A; O'Bryan JP; McMenamin M; Hou Y; Kaplan JH; Fukai T; Ushio-Fukai M
Nat Commun; 2021 May; 12(1):3091. PubMed ID: 34035268
[TBL] [Abstract][Full Text] [Related]
17. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications.
Tarin M; Babaie M; Eshghi H; Matin MM; Saljooghi AS
J Transl Med; 2023 Oct; 21(1):745. PubMed ID: 37864163
[TBL] [Abstract][Full Text] [Related]
18. Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice.
Guthrie LM; Soma S; Yuan S; Silva A; Zulkifli M; Snavely TC; Greene HF; Nunez E; Lynch B; De Ville C; Shanbhag V; Lopez FR; Acharya A; Petris MJ; Kim BE; Gohil VM; Sacchettini JC
Science; 2020 May; 368(6491):620-625. PubMed ID: 32381719
[TBL] [Abstract][Full Text] [Related]
19. Involvement of CTR1 and ATP7A in lead (Pb)-induced copper (Cu) accumulation in choroidal epithelial cells.
Zheng G; Zhang J; Xu Y; Shen X; Song H; Jing J; Luo W; Zheng W; Chen J
Toxicol Lett; 2014 Feb; 225(1):110-8. PubMed ID: 24316150
[TBL] [Abstract][Full Text] [Related]
20. Cellular mechanisms of the cytotoxicity of the anticancer drug elesclomol and its complex with Cu(II).
Hasinoff BB; Wu X; Yadav AA; Patel D; Zhang H; Wang DS; Chen ZS; Yalowich JC
Biochem Pharmacol; 2015 Feb; 93(3):266-76. PubMed ID: 25550273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
